BICX

Healthcare Medical Care Facilities

BioCorRx Inc.

$0.20

+0.00 +0.00% today

Price History

Not enough data

Key Stats

Market Cap

5.98M

Avg Volume

3,276

EPS

-$0.13

52W High

$1.28

52W Low

$0.15

Div. Yield

0.0%

Valuation

Forward P/E

-2.87

P/B Ratio

-0.49

P/S Ratio

9.19

EV/EBITDA

-1.58

EV/Revenue

12.34

Margins

Gross Margin 70.5%

Operating Margin (1666.0%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

(50.6%)

Return on Assets

(73.4%)

Liquidity & Leverage

Current Ratio

0.07

Quick Ratio

0.02

Total Cash

21,237

Total Debt

2.30M

About

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. The company offers a substance use disorder recovery program, Beat Addiction Recovery, which includes cognitive behavioral therapy modules, peer support through a mobile application, and medication prescription from an independent treating physician; and the UnCraveRx weight loss management program, a medication-assisted weight loss program that includes access to concierge on-demand wellness specialists. It also develops BICX101, an injectable and implantable naltrexone product; BICX102, a long-acting naltrexone implant that can last several months for opioid dependence and alcohol use disorders; and BICX104, a biodegradable, long-acting subcutaneous pellet of naltrexone for the treatment of opioid use disorder. The company licenses and distributes its program to healthcare providers and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. was founded in 2009 and is based in Anaheim, California.